Cedar Mountain Advisors’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.68K Hold
410
– – ﹤0.01% 571
2026
Q2
$7.36K Hold
410
– – ﹤0.01% 579
2026
Q1
$3.86K Buy
410
+397
+3,054% +$4.36K ﹤0.01% 723
2025
Q4
$161 Buy
+13
New +$173 ﹤0.01% 684

Other funds holding IART

Cedar Mountain Advisors's IART Position: Q3 2026 in Review

Cedar Mountain Advisors held its Integra LifeSciences (IART) position steady in Q3 2026 at 410 shares worth $6.68K. The position accounts for ﹤0.01% of the portfolio, ranked #571.

Cedar Mountain Advisors first reported a position in IART in Q4 2025 and has held it in 4 quarters since. The position peaked at $7.36K in Q2 2026. 25 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Cedar Mountain Advisors held 410 shares of Integra LifeSciences worth $6.68K as of Q3 2026.
  • Cedar Mountain Advisors left its Integra LifeSciences share count unchanged in Q3 2026.
  • Integra LifeSciences made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q3 2026, its #571 holding.
  • Cedar Mountain Advisors first reported a position in Integra LifeSciences in Q4 2025 and has held it in 4 quarters since.
  • Cedar Mountain Advisors's Integra LifeSciences position peaked at $7.36K in Q2 2026.
  • 25 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.